CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

HealthSCOPE Benefits

HealthSCOPE Benefits is committed to maintain the exclusive focus of managinghealthcare costs for client companies, to provide unsurpassed customer serviceand seamless benefits administration, managed care, and informatics servicesand to support client

MedicineNet

MedicineNet is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United! International Laboratories

United! International Laboratories is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Roche Diagnostics North America

At Roche Diagnostics, our focus is to improve the lives of patients, from research to lab tests to personalized healthcare; we touch the entire spectrum of diagnostics users. Roche Diagnostics is a member of the Roche Group, which is headquartered in Basel, Switzerland. Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world`s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche`s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. Roche has over 90,000 employees worldwide and invested over 9 billion Swiss francs in R&D. Roche Diagnostics` North American headquarters, located in Indianapolis, has about 4,200 employees and is home to U.S. research and development, laboratory, manufacturing, distribution, information technology and administrative operations.

Julius A. Laitin Enterprises

Julius A. Laitin Enterprises is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.